During the past decade, Hubei Provincial Hospital of TCM conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hubei Provincial Hospital of TCM" #1 sponsor was "ShuGuang Hospital" with 2 trials, followed by "Chen Xiangmei" with 1 trials sponsored, "Chinese PLA General Hospital" with 1 trials sponsored, "Huazhong University of Science and Technology" with 1 trials sponsored and "Maoxiang Group Jilin Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hubei Provincial Hospital of TCM" #1 collaborator was "Beijing Ditan Hospital" with 2 trials as a collaborator, "Beijing YouAn Hospital" with 2 trials as a collaborator, "China-Japan Friendship Hospital" with 2 trials as a collaborator, "Fifth Hospital of Shijiazhuang City" with 2 trials as a collaborator and "Guangxi Ruikang Hospital" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hubei Provincial Hospital of TCM" are "Adverse Drug Reaction" (1 trials), "Chronic Kidney Disease" (1 trials), "Cough" (1 trials), "Functional Constipation" (1 trials) and "Hepatitis B Virus Related Cirrhosis" (1 trials). Many other conditions were trialed in "Hubei Provincial Hospital of TCM" in a lesser frequency.

Most popular intervention types in "Hubei Provincial Hospital of TCM" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abelmoschus manihot" (1 trials), "Abelmoschus manihot (AM)" (1 trials), "Acetaminophen tablets" (1 trials), "Entecavir + Fuzheng Huayu Tablet" (1 trials) and "Entecavir + Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hubei Provincial Hospital of TCM" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hubei Provincial Hospital of TCM". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hubei Provincial Hospital of TCM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hubei Provincial Hospital of TCM, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".

Hubei Provincial Hospital of TCM has several departments that took part in Clinical trials: "Wuhan Pulmonary Hospital" - 3 trials, "Shaanxi Provincial Center for Disease Control and Prevention" - 2 trials